Quart Barry D's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Feb 12, 2026
- Accession no.
- 0001384243-26-000004
- Filed
- Feb 12, 2026
- Trade date
- Feb 10-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $126.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quart Barry DCIK 0001384243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +110 | $15.47 | +$1,701.7 | 12,656 | Direct | |
| Feb 10, 2026 | Class A Ordinary Share | SSaleDisposed | −110 | $45.00 | −$4,950 | 12,546 | Direct | |
| Feb 12, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +2,690 | $15.47 | +$41,614.3 | 15,236 | Direct | |
| Feb 12, 2026 | Class A Ordinary Share | SSaleDisposed | −2,690 | $45.00 | −$121,050 | 12,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Class A Ordinary Shares | MOption exerciseDisposed | −110 | $0.00 | $0 | 2,690 | Direct | |
| Feb 12, 2026 | Class A Ordinary Shares | MOption exerciseDisposed | −2,690 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.